IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $210,420,282 | +14.3% | 13,258,997 | +35.9% | 0.04% | +20.0% |
Q2 2023 | $184,037,203 | +385.8% | 9,752,899 | -1.1% | 0.04% | +337.5% |
Q1 2023 | $37,880,774 | -17.2% | 9,864,785 | +6.9% | 0.01% | -11.1% |
Q4 2022 | $45,764,472 | -4.3% | 9,226,708 | -7.8% | 0.01% | -10.0% |
Q3 2022 | $47,835,000 | -0.8% | 10,007,505 | -6.6% | 0.01% | 0.0% |
Q2 2022 | $48,227,000 | -22.4% | 10,717,085 | -18.0% | 0.01% | -9.1% |
Q1 2022 | $62,182,000 | -39.7% | 13,063,484 | -6.0% | 0.01% | -31.2% |
Q4 2021 | $103,157,000 | +29.3% | 13,902,498 | -1.2% | 0.02% | +14.3% |
Q3 2021 | $79,765,000 | -17.1% | 14,068,108 | -3.6% | 0.01% | -12.5% |
Q2 2021 | $96,166,000 | -37.5% | 14,592,570 | -23.2% | 0.02% | -40.7% |
Q1 2021 | $153,928,000 | +8.1% | 19,003,480 | -13.9% | 0.03% | +3.8% |
Q4 2020 | $142,442,000 | +71.4% | 22,084,103 | -4.3% | 0.03% | +52.9% |
Q3 2020 | $83,089,000 | -22.5% | 23,080,128 | -1.0% | 0.02% | -29.2% |
Q2 2020 | $107,233,000 | +64.2% | 23,311,638 | +21.7% | 0.02% | +41.2% |
Q1 2020 | $65,305,000 | +30559.6% | 19,151,382 | +45818.9% | 0.02% | – |
Q4 2019 | $213,000 | -49.6% | 41,707 | -78.6% | 0.00% | – |
Q2 2019 | $423,000 | +274.3% | 194,701 | +366.8% | 0.00% | – |
Q1 2019 | $113,000 | -38.9% | 41,710 | +114.0% | 0.00% | – |
Q3 2018 | $185,000 | -92.3% | 19,495 | -92.1% | 0.00% | -100.0% |
Q2 2018 | $2,408,000 | +12.9% | 247,496 | +22.1% | 0.00% | – |
Q1 2018 | $2,133,000 | -18.2% | 202,738 | -50.1% | 0.00% | -100.0% |
Q4 2017 | $2,607,000 | +9.3% | 406,661 | +30.4% | 0.00% | 0.0% |
Q3 2017 | $2,385,000 | +387.7% | 311,763 | +70.7% | 0.00% | – |
Q3 2016 | $489,000 | -46.0% | 182,591 | -37.9% | 0.00% | – |
Q2 2016 | $905,000 | -62.0% | 293,899 | +5.1% | 0.00% | -100.0% |
Q1 2016 | $2,383,000 | -20.0% | 279,713 | +27.5% | 0.00% | 0.0% |
Q4 2015 | $2,977,000 | -55.6% | 219,386 | -65.4% | 0.00% | -50.0% |
Q3 2014 | $6,706,000 | -56.7% | 633,248 | -51.6% | 0.00% | -50.0% |
Q2 2014 | $15,495,000 | -66.8% | 1,307,500 | -58.2% | 0.00% | -69.2% |
Q1 2014 | $46,679,000 | +0.0% | 3,126,551 | -1.7% | 0.01% | 0.0% |
Q4 2013 | $46,661,000 | -18.3% | 3,180,697 | -5.3% | 0.01% | -27.8% |
Q3 2013 | $57,145,000 | -2.4% | 3,357,517 | -4.8% | 0.02% | -5.3% |
Q2 2013 | $58,533,000 | – | 3,528,192 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |